High-efficiency retroviral infection of primary myoblasts.
about
The molecular chaperone HSP70 binds to and stabilizes NOD2, an important protein involved in Crohn diseaseCSX/Nkx2.5 modulates differentiation of skeletal myoblasts and promotes differentiation into neuronal cells in vitroRIP2, a checkpoint in myogenic differentiation.microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7Stac3 inhibits myoblast differentiation into myotubes.Induction of aberrant vascular growth, but not of normal angiogenesis, by cell-based expression of different doses of human and mouse VEGF is species-dependent.Highly conserved RNA sequences that are sensors of environmental stress.G-protein coupled receptor 56 promotes myoblast fusion through serum response factor- and nuclear factor of activated T-cell-mediated signalling but is not essential for muscle development in vivoPleiotrophin gene therapy for peripheral ischemia: evaluation of full-length and truncated gene variantsMyoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis.Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purificationTet B or not tet B: advances in tetracycline-inducible gene expressionVEGF dose regulates vascular stabilization through Semaphorin3A and the Neuropilin-1+ monocyte/TGF-β1 paracrine axisGrowth stimulation of primary B cell precursors by the anti-phosphatase Sbf1.IGF-I increases bone marrow contribution to adult skeletal muscle and enhances the fusion of myelomonocytic precursors.The effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarctionLong-term safety and stability of angiogenesis induced by balanced single-vector co-expression of PDGF-BB and VEGF164 in skeletal muscle.CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy.Graded transcriptional response to different concentrations of a single transactivator.CCAAT/enhancer binding protein beta protects muscle satellite cells from apoptosis after injury and in cancer cachexiaFACS-purified myoblasts producing controlled VEGF levels induce safe and stable angiogenesis in chronic hind limb ischemia.Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells.Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis.Doxycycline-inducible retroviral expression of green fluorescent protein in immortalized human keratinocytes.VEGF over-expression in skeletal muscle induces angiogenesis by intussusception rather than sprouting.Angiopoietin-1 for myocardial angiogenesis: a comparison between delivery strategies.EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.
P2860
Q24296753-2140776B-7F89-410A-B731-07BC19D69C7FQ24338240-EEE396B2-F310-4426-A9B3-2EBCA6A1A816Q24537698-6BA0FA16-B7E3-4248-B3D7-21A6245EB904Q24615529-77D5ADC2-5CFB-4832-870F-A7CE916E26F6Q30009426-FD89E663-AAF2-40AE-8396-551758C5E601Q33586324-17D191A9-19A5-4A32-8461-964C25B67C09Q33781775-9530E063-C52D-4A6D-AE43-729672015920Q34376127-071620C8-6608-4760-B570-83EDCA14E6A1Q34695480-F5A2B088-5083-462A-9A04-1A7404EA2B8EQ35554334-32A20F3F-6616-4561-9AAC-1CC00163E469Q35851399-D624B61E-1AF7-4FC0-9E03-657287CAE42CQ35959206-2D4540CB-31FE-418E-A083-914726DB8FABQ36159478-2F4C41DA-9449-45A4-8272-054615D12B85Q36261980-A564298C-714F-4283-A47E-C64628B29FB2Q36320501-91E446E1-DBB3-4474-9CF2-50F8178DE334Q36374351-6DBE8254-CA3A-4E07-8637-4599A33276F0Q36587779-ABFF79C1-5754-40CF-A238-E70826A899E8Q36675292-7CF4DC4F-3BC8-4FD2-915F-E4C934C3AA9FQ36796077-EB7D7461-8322-4C0D-BBE7-9C10AF6FB1BCQ36847549-49AE0BA5-3383-48EB-AF91-7761D5DB3F1CQ37295222-7C3B7F0F-C66C-4D96-B438-88F3FC743D0CQ38613503-CDEA38BD-6C7E-489E-8E47-19DC6B8ACE5EQ40553670-28F9E8F4-935B-4AED-8E2A-F1F9A6CC58D9Q40720118-51BF1045-FB61-4A7B-B36A-FB94AE3BE65BQ44037274-8CC5050E-3B59-46C8-AE1E-7476721AFCD7Q51772632-A856D538-1EF8-4A4C-B2C6-14DE09272BADQ55004289-402C9622-F822-4672-A395-B10BBC2D67F1
P2860
High-efficiency retroviral infection of primary myoblasts.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
High-efficiency retroviral infection of primary myoblasts.
@en
High-efficiency retroviral infection of primary myoblasts.
@nl
type
label
High-efficiency retroviral infection of primary myoblasts.
@en
High-efficiency retroviral infection of primary myoblasts.
@nl
prefLabel
High-efficiency retroviral infection of primary myoblasts.
@en
High-efficiency retroviral infection of primary myoblasts.
@nl
P356
P1476
High-efficiency retroviral infection of primary myoblasts.
@en
P2093
P304
P356
10.1007/BF02721371
P577
1997-05-01T00:00:00Z